User profiles for G. LOPALCO
Giuseppe LopalcoAssistant Medical Director, Rheumatology Unit, Bari Verified email at uniba.it Cited by 5193 |
[HTML][HTML] Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases
The interleukin (IL)-1 family member IL-1α is a ubiquitous and pivotal pro-inflammatory
cytokine. The IL-1α precursor is constitutively present in nearly all cell types in health, but is …
cytokine. The IL-1α precursor is constitutively present in nearly all cell types in health, but is …
[HTML][HTML] Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives
… Copyright © 2015 Giuseppe Lopalco et al. This is an open access article distributed
under the Creative … Giuseppe Lopalco and Luca Cantarini equally contributed to this work. …
under the Creative … Giuseppe Lopalco and Luca Cantarini equally contributed to this work. …
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease
Behçet's disease (BD) is a multi-systemic disorder of unknown etiology characterized by
relapsing oral–genital ulcers, uveitis, and involvement of the articular, gastrointestinal, …
relapsing oral–genital ulcers, uveitis, and involvement of the articular, gastrointestinal, …
Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study
…, F Schiavon, T Neumann, G Lopalco… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study
This study aimed to evaluate the role of interleukin (IL)-1 inhibitors anakinra (ANA) and
canakinumab (CAN) in the treatment of Behçet’s disease (BD)-related uveitis. Multicenter …
canakinumab (CAN) in the treatment of Behçet’s disease (BD)-related uveitis. Multicenter …
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study
Aims Novel therapies are needed for recurrent pericarditis, particularly when corticosteroid
dependent and colchicine resistant. Based on limited data, interleukin-1 blockade with …
dependent and colchicine resistant. Based on limited data, interleukin-1 blockade with …
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study
Growing data have provided encouraging results on the use of interleukin (IL)-1 inhibitors in
Behçet’s disease (BD). This study was aimed at reporting the largest experience with anti-IL-…
Behçet’s disease (BD). This study was aimed at reporting the largest experience with anti-IL-…
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study
The study aim was to evaluate the efficacy of adalimumab (ADA) in a large series of Behçet’s
disease (BD)-related uveitis. We performed a multicenter retrospective observational study …
disease (BD)-related uveitis. We performed a multicenter retrospective observational study …
[HTML][HTML] Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset Still's disease: a multicentre retrospective observational study
Background: Interleukin (IL)-1 plays a crucial role in the pathogenesis of Adult onset Still’s
disease (AOSD). Objectives: To evaluate the efficacy and safety of anakinra (ANA) and …
disease (AOSD). Objectives: To evaluate the efficacy and safety of anakinra (ANA) and …
[PDF][PDF] Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection
European and Asian studies report conflicting data on the risk of hepatitis B virus (HBV)
reactivation in rheumatologic patients with a previously resolved HBV (prHBV) infection …
reactivation in rheumatologic patients with a previously resolved HBV (prHBV) infection …